Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
◆ Novo Nordisk brings €6bn trade days after CEO leaves ◆ Tranches priced with similar premiums ◆ No sign of investor fatigue for jumbo corporate trades
-
DocMorris announces Sfr200m rights issue expected in May
-
Stock drops 17% in highly volatile market
-
Deal follows steep share price fall
-
-
The pay-off of keeping work at bay when it comes to family is bigger than the downside